Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • cllorens
    Member
    • Nov 2011
    • 44

    PhD Thesis in Bioinformatics (Opathy Project Marie Curie ITN)

    We currently have an Early Stage Researcher (ESR) position for a PhD Thesis available for 3 years of duration in the core bioinformatic team of Biotechvana.

    The Thesis project entitled "Integrative genomics/proteomics of yeast infections" belongs to the H2020 Marie Curie ETN Project "From Omics to Patient: Improving Diagnostics of Pathogenic Yeasts (OPATHY)" and will be supervised by Dr Carlos Llorens (Biotechvana), and Dr Toni Gabaldon (Centre for Genomic Regulation). The main objetive for this particular ESR project consists of developing the computational infrastructure for the integrative analysis of disparate highthroughput methodologies (i.e. genomics and proteomics). This includes the development of a database (OPATHY Database) and different bioinformatics tools and pipelines for storing and analyzing relevant omicS data and metadata to enable data-driven discoveries of new biomarkers of yeast infections by mapping transcriptomics and/or proteomics data. The ESR will also BE enroled in bioinformatic tasks related with the analysis of data.

    Applicants should hold a Master's degree (or equivalent) in Bioinformatics, Computational Sciences, Physics, or Biological Sciences.The ESR candidate must have demonstrated programming skills in Php and previous experience in development of SQL databases, in particular MySQL and Wikis.Experience in other programming/scripting languages, Particularly Python or JAva would be an advantage, as would also be previous knowledge of molecular biology and/or NGS analysis. The ESR should be comfortable developing software in a primarily Unix-based environment, and be familiar with development tools such as CVS.We are looking for highly motivated PhD candidate with good communication and interpersonal skills. Furthermore, candidates should demonstrate solid problem solving skills, excellent attention to detail, and a desire to work in an international environment. Good English language skills are a requirement.

    More details, and information on how to apply, please visit the OPATHY webpage (http://www.opathy.eu/content/application-procedure) or contact Dr Carlos Llorens at Biotechvana ( [email protected]) or Toni Gabaldon ([email protected]) at CRG.
  • cllorens
    Member
    • Nov 2011
    • 44

    #2
    For those of you guys that contacted me personally wondering about the position,
    Our consortium not only offers the PhD position with us but also 12 other PhD positions in distinct european centers.
    I have created a new thread (http://seqanswers.com/forums/showthread.php?t=63298) with the whole details about the Opathy project and how to apply
    Best
    carlx

    Comment

    Latest Articles

    Collapse

    • mylaser
      Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by mylaser
      Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
      If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
      This guide explains everything you need to know about...
      Today, 01:13 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-02-2026, 11:08 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Working...